Contour ProtégéAI

by MIM Software  · Based in United States → — AI Auto-Contouring for Precision Radiation Oncology
Oncology Radiology
Website
Claim this tool
Is this the maker? Claim the company →

Contact for pricing
Regulatory Status Disclosed

Overview

Contour ProtégéAI by MIM Software is an advanced AI auto-contouring solution designed for medical imaging, primarily within Radiation Oncology. It leverages machine learning algorithms to automatically segment anatomical structures and organs at risk (OARs) on CT and MR images. This tool aims to significantly enhance the efficiency and accuracy of radiation therapy treatment planning by reducing the time-consuming manual contouring process. It supports flexible deployment options, including both cloud-hosted and local installations, and integrates seamlessly into existing clinical workflows. Recent updates, such as Contour ProtégéAI+, introduce zero-click auto-contouring capabilities for structures like lymph nodes, further streamlining the planning process.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Next-generation segmentation utilizing deep learning algorithms
  • Auto-segmentation begins immediately upon image reception
  • Powered by MIMapp Catalystu2122 cloud-based platform
  • No additional hardware required for deployment
  • Pre-trained models, no need for user-contoured datasets
  • Quick to deploy and scale for high patient volumes
  • Supports both cloud-hosted and local deployment options
  • Zero-click AI auto-contouring for specific structures (Contour Protu00e9gu00e9AI+)
  • Generates head & neck and breast lymph node level structures, and OARs
  • Results exported directly to Treatment Planning Systems (TPS) or MIM software

Use Cases

  • Radiation oncology treatment planning and segmentation
  • Enhancements for Molecular Radiotherapy (MRT)
  • Aiding adaptive radiation therapy
  • Transferring contours to radiation therapy treatment planning systems
  • Archiving contours for patient follow-up and management
  • Quantitative analysis of anatomical structures

What Physicians Need to Know

Key Capabilities
Contour Protu00e9gu00e9AI is an AI auto-contouring solution primarily for Radiation Oncology and Molecular Radiotherapy. It utilizes dynamic deep learning algorithms for next-generation segmentation, offering zero-click auto-contouring for organs-at-risk (OARs) and lymph node levels. It supports various anatomical locations including head & neck, thorax, pelvis, prostate, and abdomen.
Clinical Utility
The tool significantly reduces the time required for contouring, a traditionally time-consuming task in radiation therapy, thereby increasing clinical efficiency and expediting simulation-to-treatment times. It aims to improve overall contour quality and provides accurate initial results that require minimal editing, allowing clinicians to focus more on treatment planning and complex cases. It also supports enhancements for Molecular Radiotherapy (MRT) and adaptive therapy.
Integration Options
Contour Protu00e9gu00e9AI is designed for flexible implementation, seamlessly integrating into existing departmental workflows with minimal effort. It is vendor-neutral and supports integration with various PACS vendors and major treatment planning systems such as Eclipse, RayStation, Monaco, and Pinnacle. It offers both cloud-hosted and local deployment options.
Compliance Status
The software has received multiple FDA 510(k) clearances for its updated contour models (e.g., versions 4.0 and 4.1.1). It is also approved by Health Canada and has been recommended by the National Institute for Health Care Excellence (NICE) in England for use within the NHS for radiotherapy treatment planning.
Pricing Model
The specific pricing model (e.g., subscription, perpetual license, tiered pricing) for Contour Protu00e9gu00e9AI is not publicly disclosed. It is typically offered as a commercial software license, and interested parties are advised to contact MIM Software directly for details.
User Experience
The tool features 'zero-click' auto-contouring, where segmentation begins automatically upon receiving simulation images, reducing manual effort. User feedback is actively incorporated into product updates to continuously improve contour quality and user experience, leading to greater time savings.
Support Quality
MIM Software is a global provider with a commitment to customer-centered innovation. Product development, including updates to Contour Protu00e9gu00e9AI, is guided by direct input and feedback from clinicians, indicating a responsive and user-driven support approach.
Implementation Complexity
Contour Protu00e9gu00e9AI is designed for flexible and rapid implementation, requiring minimal effort to integrate into existing workflows. It can be quickly deployed and scaled to accommodate varying patient volumes and supports both cloud-hosted and local deployment without requiring additional hardware.
Evidence Base
The AI auto-contouring solution has been validated by leading institutions, with research presented at conferences such as AAPM, demonstrating its accuracy and efficiency in clinical use, particularly for complex head and neck cancer cases. Studies have shown its performance to be comparable or superior to atlas-based segmentation and manual contouring, with detailed white papers available on its neural network theory, training, validation, and testing results.
Physician Tip

Leverage Contour Protu00e9gu00e9AI to significantly reduce the time spent on manual contouring, freeing up valuable time for more complex treatment planning, adaptive therapy assessments, and direct patient interaction. While the AI provides highly accurate initial contours, always maintain clinical oversight and review, making edits as necessary to ensure optimal patient care. Utilize its capabilities to standardize contouring practices across your department, potentially improving consistency and quality.

Contour Protu00e9gu00e9AI's vendor-neutral design and compatibility with major PACS and Treatment Planning Systems (TPS) like Eclipse, RayStation, Monaco, and Pinnacle ensure broad applicability. Its flexible deployment options (cloud or local) allow it to fit into diverse IT infrastructures, minimizing disruption during implementation. This broad integration capability makes it a versatile addition to most radiation oncology workflows.

Details

Category Oncology AI, Radiology & Imaging AI
Pricing Contact for pricing
DeploymentCloud-hosted and local deployment
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

Contour ProtégéAI has received multiple FDA 510(k) clearances, including for updated contour models (version 4.0 and ProtégéAI+) for Radiation Oncology segmentation, additional structures, and enhancements for Molecular Radiotherapy. The FDA 510(k) premarket notification number K231765 was cleared on November 8, 2023.
Integrations
EHR Not specified
Specialties Oncology, Radiology

What the Web Says

Contour Protu00e9gu00e9AI, developed by MIM Software (a GE HealthCare Company), is an AI-powered auto-contouring software designed for radiation therapy planning. It aims to automate the time-intensive process of delineating anatomical structures on medical images, thereby improving efficiency and consistency in treatment planning. The software has received FDA 510(k) clearance and is recommended for use in England's National Health Service (NHS).

Overall: Positive

Strengths

  • Significantly reduces the time needed for contouring organs-at-risk (OARs).
  • Improves consistency and quality of contours compared to manual or atlas-based methods.
  • Accurately delineates OARs for auto-segmentation tasks on CT images without user intervention.
  • Can handle difficult cases with less contrast and more homogeneous borders, where atlas-based methods struggle.
  • Integrates seamlessly into existing clinical workflows with minimal effort.
  • FDA cleared with a predetermined change control plan for future updates and enhancements.

Limitations

  • Some contours may still require minor editing or touch-ups by a physician.
  • A minority of patients may still require manual contouring and more in-depth physician review.
  • Performance can vary for certain organs, with the esophagus showing the worst performance in one study.
  • Detailed information on the underlying AI method (neural network framework) is not readily available to the public.
  • May not be available in all countries.

Based on reviews from: MIM Software, Oncology and Radiotherapy, PMC, YouTube, Medical Product Outsourcing (MPO), Applied Radiation Oncology

Last updated: 2026-07-18

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Contour ProtégéAI

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

PR Newswire
MIM Software Inc. Announces FDA Clearance of Contour Protu00e9gu00e9AIu00ae 4.0 Models
MIM Software Inc. announced FDA clearance for its Contour Protu00e9gu00e9AI 4.0, an AI auto-contouring solution with improved algorithms for Radiation Oncology segmentation, additional structures, and enhancements for Molecular Radiotherapy (MRT). This update aims to integrate seamlessly into existing workflows, offering exceptional contouring results.
2023-05
Applied Radiation Oncology
FDA Clears MIM Software's Contour Protu00e9gu00e9AI 4.0
MIM Software Inc. received FDA clearance for Contour Protu00e9gu00e9AI 4.0, which features enhanced algorithms for radiation oncology segmentation, new structures, and improvements for molecular radiotherapy. The company states that initial testing showed significant improvement in overall contour quality.
2023-05
MIM Software Inc.
Contour Protu00e9gu00e9AIu00ae Among AI Technologies Recommended for Use in Radiotherapy Treatment Planning in England
AI contouring technologies, including Contour Protu00e9gu00e9AI, have been recommended for use in radiotherapy treatment planning within England's National Health Service (NHS) by the National Institute for Health Care Excellence (NICE). This marks the first time NICE has recommended AI in healthcare, citing potential cost reduction and more time for healthcare providers.
2023-08
MIM Software Inc.
MIM Software Inc. Releases Version 1.1.3 for Contour Protu00e9gu00e9AI Auto-Contouring Software
MIM Software Inc. released version 1.1.3 of its AI auto-contouring solution, Contour Protu00e9gu00e9AI, which includes refinements to the algorithm based on direct customer feedback. These quality improvements aim to provide users with even greater time savings in their workflows.
2024-01
MIM Software Blog
Contour Protu00e9gu00e9AIu00ae Validated for Head and Neck Auto-Segmentation
MIM Software's AI auto-segmentation solution, Contour Protu00e9gu00e9AI, was validated for use in complex head and neck cancer in a recent AAPM presentation.
2023-04
MDPI (International Journal of Environmental Research and Public Health)
Comparison of Two Auto-Contouring Systems for Head and Neck Organs at Risk to Institutional Reference Standard in Radiotherapy Planning
This study quantitatively and qualitatively compared the performance of MIM Contour Protu00e9gu00e9AI and Limbus Contour in auto-contouring head and neck organs at risk (OARs) for radiotherapy planning. The study found that both systems showed good subjective quality of auto-contours.
2026-06
MIM Software Inc.
Health Canada Approves Contour Protu00e9gu00e9AI AI Auto-Contouring Software
MIM Software Inc. received approval from Health Canada for its AI auto-contouring solution, Contour Protu00e9gu00e9AI. This approval aims to help clinics achieve quicker simulation to treatment times and reduce the burden of contouring.
2022-11
Health Canada
Regulatory Decision Summary - CONTOUR PROTEGEAI - Health Canada
This regulatory decision summary details the amendment of a Class 3 Medical Device Licence for Contour Protu00e9gu00e9AI, an accessory to MIM software that automatically creates contours on medical images using machine-learning algorithms. The amendment includes a software upgrade to version 1.4.0, adding new and updated neural network models and quality improvements.
2021-07

Videos

Product demos, reviews, and walkthroughs for Contour ProtégéAI.

View all on YouTube

Frequently Asked Questions

Contour Protu00e9gu00e9AI is designed to seamlessly integrate into existing radiation oncology workflows, connecting with systems like Eclipseu2122, RayStationu00ae, Monacou00ae, and Pinnacle. It automates the deep learning segmentation of organs at risk (OARs) and facilitates automated preparation for physician target volume (PTV) contouring, significantly reducing the time needed for these tasks.
Contour Protu00e9gu00e9AI has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and approval from Health Canada. While HIPAA doesn't have AI-specific provisions, its existing rules govern how Protected Health Information (PHI) is used with AI tools, and vendors like MIM Software are expected to comply, often through Business Associate Agreements.
Contour Protu00e9gu00e9AI differentiates itself by offering improved algorithms for radiation oncology segmentation and molecular radiotherapy, with initial testing showing good improvement in overall contour quality. It has been validated to accurately delineate OARs on CT images without user intervention, completing segmentation in under five minutes, which is significantly faster than manual methods.
While specific pricing for Contour Protu00e9gu00e9AI is not publicly detailed, healthcare AI software often uses subscription-based models, sometimes with volume-based metrics or tiered pricing. Factors influencing cost typically include the number of users, integration needs with existing systems, deployment type (cloud-based vs. on-premise), and the level of support and training required.
Like many AI systems, Contour Protu00e9gu00e9AI's performance is dependent on the quality and diversity of its training data, and potential biases can arise if datasets lack representation for certain patient groups. Human oversight by a trained healthcare professional is consistently recommended to ensure accuracy, address potential algorithmic biases, and maintain clinical accountability, especially in high-stakes medical decisions.
Contour Protu00e9gu00e9AI, as a healthcare AI tool, is expected to adhere to stringent data security protocols, including robust encryption and identity verification. Healthcare organizations using AI tools must implement data privacy and security protocols, conduct regular risk assessments, and ensure compliance with regulations like HIPAA to safeguard sensitive patient data.
MIM Software, the developer of Contour Protu00e9gu00e9AI, emphasizes continuous improvement based on user feedback, suggesting a commitment to user support. Generally, successful AI adoption in healthcare requires operational planning, staff readiness, and ongoing training, with vendors often providing resources and support to ensure effective integration and use.

Related Tools

Surgical Reality Viewer
Surgical Reality
Oncology AI
Surgical Reality offers CE- and FDA-certified AI-powered 3D medical imaging and surgical planning software that transforms CT scans into patient-specific 3D models for thoracic surgery, enhancing precision in complex lung procedures.
Cancer Copilot
Color Health
Oncology AI
Color Health's Cancer Copilot, built with OpenAI, helps oncologists and clinicians identify and order workup needs for recently diagnosed patients, aiming to speed up time to cancer treatment. This AI tool is designed to expand cancer expertise, speed decisions, and improve care, reducing a two-hour clinical task to 10 minutes with over 95% validated accuracy.
Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.
Synapse Lung Nodule AI
Fujifilm Corporation
Oncology AI
Fujifilm's Synapse Lung Nodule AI is an AI software algorithm for detecting pulmonary nodules on CT imaging, aiming to support early detection and treatment of lung cancer.
On request
RadOncAI
Informai (for RadOncAI product) / Global Network for AI in Radiation Oncology (for RadoncAI.net)
Oncology AI
RadOncAI is an AI solution by Informai designed to optimize and enhance radiation oncology workflows, improving efficiency and accuracy in treatment planning and delivery.
FAITH project (Fatigue Therapy – AI-supported Diagnosis and Therapy of Tumour-associated Fatigue Syndrome)
Fimo Health GmbH (Consortium Leader)
Mental & Behavioral Health AI
The FAITH project is developing an AI-based solution for the diagnosis and therapy of tumor-associated fatigue syndrome in cancer patients. It uses wearable sensors, a smartphone app, and artificial intelligence to provide individualized therapy recommendations and monitor mental health.

See all Oncology AI tools →

More from MIM Software

Contour ProtégéAI+
MIM Software
Oncology AI
MIM Software's Contour ProtégéAI+ is a zero-click AI auto-contouring solution that automates the segmentation of anatomical structures on medical images for radiation oncology and diagnostic imaging, enhancing efficiency in treatment planning.
Contact for pricing

View company profile →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.